Here’s Why CVD Equipment, Micron and Three Other Stocks Are in Spotlight Today

Page 2 of 2

Micron Technology, Inc. (NASDAQ:MU)’s stock has gained 7% so far today after investment firm Susquehanna upgraded to stock to “Positive” from “Neutral” and upped its price target to $18 from $10. Susquehanna’s analyst Mehdi Hosseini said that pricing trends for PC & Server DRAM are improving, and thinks that PC and Servers business is Micron’s “sweet spot.” Among the funds tracked by us, 51 funds were bullish on Micron Technology, Inc. (NASDAQ:MU) at the end of March, down from 64 funds a quarter earlier.

Follow Micron Technology Inc (NASDAQ:MU)

EC Grants Marketing Authorization to Gilead Sciences’ Drug

Shares of Gilead Sciences, Inc. (NASDAQ:GILD) are trading  in the green today as the company announced that the European Commission has granted marketing authorization  to Odefsey, its tablet for the treatment of HIV-1 infection. Odefsey is Gilead’s second single tablet regime (STR) to receive marketing authorization in the European Union. In November 2015, the European Commission approved Genvoya. The hedge fund sentiment is pretty strong towards Gilead Sciences, Inc. (NASDAQ:GILD). A total of 93 hedge funds among those tracked by us amassed approximately $4 billion worth of the company’s stock as of the end of the first quarter. John Armitage’s Egerton Capital Limited owns about 4.52 million shares of the company.

Follow Gilead Sciences Inc. (NASDAQ:GILD)

Boeing Strikes Deal with Iran

Investors have been watching Boeing Co (NYSE:BA) closely lately after the company said earlier this week that it had signed a Memorandum of Agreement (MOA) to sell jetliners to Iran. Monetary details of the agreement were not disclosed by the company, but an Iranian official said the deal could be valued at $25 billion. The deal would be one of the biggest between any US company and Iran since trade sanctions on Iran had been eased. In other news, earlier today, Morgan Stanley initiated coverage on Boeing with an ‘overweight’ rating and a $153 price target. Edgar Wachenheim’s Greenhaven Associates is one of 37 hedge funds from our database that reported stakes in Boeing Co (NYSE:BA) as of the end of the first quarter. It owns approximately 1.26 million shares of the company.

Follow Boeing Co (NYSE:BA)

Disclosure: None

Page 2 of 2